Hepatitis c Trials in Seattle, United States
Conditions / Hepatitis c / Seattle, United States
Hepatitis c is a medical condition with active clinical research programs worldwide.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00164372 | Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users | COMPLETED | PHASE2/PHASE3 |
| NCT01482767 | Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection | COMPLETED | PHASE3 |
| NCT01485991 | TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy | COMPLETED | PHASE3 |
| NCT01492504 | Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial | COMPLETED | — |
| NCT00006643 | Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus | COMPLETED | — |
| NCT03707080 | Direct Acting Antiviral-Post Authorization Safety Study | COMPLETED | — |
| NCT02194998 | Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy | TERMINATED | PHASE2 |
| NCT02607800 | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy | COMPLETED | PHASE3 |
| NCT02607735 | Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy | COMPLETED | PHASE3 |
| NCT00001117 | A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection | COMPLETED | — |